Chronic lymphocytic leukemia (CLL) is a B-cell malignancy, with disease progression ranging from slow and indolent to ...
The Phase 1b/2a study will assess the safety of CNP-103 in adults (aged 18-35) and pediatrics (aged 12-17) who have Stage III or newly diagnosed (within the last 6 months) T1D as well as C-peptide ...
5don MSN
Migration to other parts of the world and leaving your homeland may not be easy for everyone, but it is situations and circumstances that make us do so. The migrant population is observed to be prone ...
MOUNTAIN VIEW, Calif., Jan. 09, 2025 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a biotechnology company committed to developing and delivering medicines to treat patients with ...
MOUNTAIN VIEW, Calif., Jan. 09, 2025 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a biotechnology company committed to developing and delivering medicines to treat patients with ...
Taken together, the contributions to the Research Topic “Key Players of the Immune System in Skin Inflammation—Allergy and Autoimmunity” collectively shed light on critical immune mechanisms ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback